2008
DOI: 10.1016/j.coi.2008.08.003
|View full text |Cite
|
Sign up to set email alerts
|

Role of B cells in systemic lupus erythematosus and rheumatoid arthritis

Abstract: SummaryB cell tolerance to many self-proteins is actively maintained by either purging self-reactive B receptors through clonal deletion and receptor editing, or by functional silencing known as anergy. However, these processes are clearly incomplete as B cell-driven autoimmune diseases still occur. The significance of B cells in two such diseases, rheumatoid arthritis and systemic lupus erythematosus, is highlighted by the ameliorative effects of B cell depletion. It remains to be determined, however, whether… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
16
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(16 citation statements)
references
References 60 publications
0
16
0
Order By: Relevance
“…Alterations in B cell immune tolerance are increasingly recognized as an important factor in the development of autoimmune rheumatoid arthritis (reviewed in [1]. Developing B cells undergo multiple consecutive tolerance checkpoints (clonal deletion, receptor editing and receptor “tuning” also known as clonal anergy ) that are responsible for the formation of immune tolerance by eliminating or silencing of self-reactive clones.…”
Section: Introductionmentioning
confidence: 99%
“…Alterations in B cell immune tolerance are increasingly recognized as an important factor in the development of autoimmune rheumatoid arthritis (reviewed in [1]. Developing B cells undergo multiple consecutive tolerance checkpoints (clonal deletion, receptor editing and receptor “tuning” also known as clonal anergy ) that are responsible for the formation of immune tolerance by eliminating or silencing of self-reactive clones.…”
Section: Introductionmentioning
confidence: 99%
“…RA is one of the first autoimmune diseases in which B cell involvement was postulated based on autoantibody production, only to later fall in disfavor because of a lack of direct correlation between autoantibodies and pathogenesis (911). However, the recent success of B cell depletion therapy in RA patients refractory to other therapies has rekindled interest in the role of B cells in this disease (1214).…”
Section: Introductionmentioning
confidence: 99%
“…Significant evidence supports the pathogenic role of autoreactive B cells in Rheumatoid arthritis (RA) [3], [4], [5], [6], [7], [8]. B cell targeted therapies are effective in RA (reviewed in [6], [9], [10]).…”
Section: Introductionmentioning
confidence: 99%